[go: up one dir, main page]

DE3586344D1 - Esterderivate vom antibiotikum l 17046. - Google Patents

Esterderivate vom antibiotikum l 17046.

Info

Publication number
DE3586344D1
DE3586344D1 DE8585113810T DE3586344T DE3586344D1 DE 3586344 D1 DE3586344 D1 DE 3586344D1 DE 8585113810 T DE8585113810 T DE 8585113810T DE 3586344 T DE3586344 T DE 3586344T DE 3586344 D1 DE3586344 D1 DE 3586344D1
Authority
DE
Germany
Prior art keywords
antibiotic
ester derivatives
directed
antimicrobial activity
positive bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585113810T
Other languages
English (en)
Other versions
DE3586344T2 (de
Inventor
Adriano Malabarba
Ambrogio Magni
Paolo Strazzolini
Bruno Cavalleri
Aldo Trani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Application granted granted Critical
Publication of DE3586344D1 publication Critical patent/DE3586344D1/de
Publication of DE3586344T2 publication Critical patent/DE3586344T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Catalysts (AREA)
  • Peptides Or Proteins (AREA)
DE8585113810T 1984-11-13 1985-10-30 Esterderivate vom antibiotikum l 17046. Expired - Fee Related DE3586344T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848428619A GB8428619D0 (en) 1984-11-13 1984-11-13 Derivatives of antibiotic l 17046

Publications (2)

Publication Number Publication Date
DE3586344D1 true DE3586344D1 (de) 1992-08-20
DE3586344T2 DE3586344T2 (de) 1993-03-11

Family

ID=10569641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585113810T Expired - Fee Related DE3586344T2 (de) 1984-11-13 1985-10-30 Esterderivate vom antibiotikum l 17046.

Country Status (13)

Country Link
US (1) US4661470A (de)
EP (1) EP0182157B1 (de)
JP (1) JPS61122300A (de)
KR (1) KR860004076A (de)
AT (1) ATE78261T1 (de)
CA (1) CA1250098A (de)
DE (1) DE3586344T2 (de)
DK (1) DK508885A (de)
ES (1) ES8704964A1 (de)
GB (1) GB8428619D0 (de)
HU (1) HU196228B (de)
IL (1) IL76996A0 (de)
ZA (1) ZA858449B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273727A3 (de) * 1986-12-30 1990-01-17 Smithkline Beecham Corporation Glykosilierte Glycopeptide
US4882313A (en) * 1987-07-31 1989-11-21 Smithkline Beckman Corporation Carboxamide derivatives of glycopeptides
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
WO2000039156A1 (en) 1998-12-23 2000-07-06 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
AR021964A1 (es) * 1998-12-23 2002-09-04 Theravance Inc Un compuesto glicopeptidico, composiciones farmaceuticas que los contienen y uso de dichos compuestos glicopeptidicos para la manufactura de un medicamento antibacteriano.
US20050004011A1 (en) * 2002-11-18 2005-01-06 Marco Cavaleri Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64486A (en) * 1980-12-18 1985-01-31 Lilly Co Eli Antibiotic a-4696 factor g,its preparation and use as feed supplement for ruminant animals
FI73697C (fi) * 1982-06-08 1987-11-09 Lepetit Spa Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2.
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives

Also Published As

Publication number Publication date
ES8704964A1 (es) 1987-04-16
HU196228B (en) 1988-10-28
ES548789A0 (es) 1987-04-16
JPS61122300A (ja) 1986-06-10
EP0182157B1 (de) 1992-07-15
ZA858449B (en) 1986-08-27
DE3586344T2 (de) 1993-03-11
HUT41053A (en) 1987-03-30
US4661470A (en) 1987-04-28
IL76996A0 (en) 1986-04-29
DK508885D0 (da) 1985-11-05
GB8428619D0 (en) 1984-12-19
EP0182157A3 (en) 1987-12-09
CA1250098A (en) 1989-02-14
KR860004076A (ko) 1986-06-16
DK508885A (da) 1986-05-14
ATE78261T1 (de) 1992-08-15
EP0182157A2 (de) 1986-05-28

Similar Documents

Publication Publication Date Title
DE69214397D1 (de) 2-Substituierte Indane-2-Carboxyalkyl-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
IE801007L (en) Penicillins
ES459784A1 (es) Un procedimiento para la preparacion de un alido carboxilicoalilico.
FI863687A0 (fi) Amider av teikoplaninfoereningar.
JO1704B1 (en) New potent compounds
DE3586344D1 (de) Esterderivate vom antibiotikum l 17046.
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
FI864453L (fi) Karboxylsyraesterderivat av deglukoteikoplanin.
ES466037A1 (es) Un procedimiento para preparar derivados de oleandomicina.
FR2369259A1 (fr) Derives de 3,3-dichloro-2-azetidinone ayant une activite anti-inflammatoire
ES455404A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
AU2857492A (en) Improved fish production
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
IE820342L (en) Penicillins
ES2079724T3 (es) Nuevos compuestos antibioticos y su produccion.
ES454009A1 (es) Un procedimiento para la preparacion de nuevos esteres de derivados del acido clavulanico.
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
UA9123A1 (uk) 1-гідроксіетил-3,5-бісгідроксиметил-1,3,5-гексагідротріазиhоh-4 як аhтимікробhа добавка для боротьби з біологічhим пошкоджеhhям мастильhо-охолоджувальhих емульсій
SU1823451A1 (ru) 2,3а-Дигидрокси-3-(4-толуоил)-3а,4-дигидро-1Н-пирроло[2,1-с][1, 4]бензоксазин-1,4-дион, проявляющий противомикробную активность в отношении кокковых форм бактерий
SU1302661A1 (ru) 3-(3,5-Диметилпиразолил-1)-6-(2-карбэтокси-1-метилэтилиден-1)гидразинопиридазин, обладающий противовоспалительной и противомикробной активностью
MX9203484A (es) Composiciones antibioticas de cefalosporina.
SU1088319A1 (ru) 2-Ацетилгидразино-4-(3,4-диоксифенил)-тиазол, проявляющий антимикробную активность в отношении кишечной палочки и золотистого стафилококка
SU1607351A1 (ru) 3-БЕНЗОИЛ-1-ФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ХИНОКСАЛИН, ПРОЯВЛЯЮЩИЙ ПРОТИВОСТАФИЛОКОККОВУЮ АКТИВНОСТЬ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee